Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2009 | 10-2008 | 10-2007 | 12-2006 | 10-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 660 | 60 | 4,042 | N/A | N/A |
| TOTAL | $696 | $99 | $4,242 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 55 | 91 | 116 | N/A | N/A |
| Intangibles | 1,372 | 1,137 | 1,098 | 0 | 0 |
| Other Non-Current Assets | 592 | 4 | 4 | 0 | 0 |
| TOTAL | $2,018 | $1,232 | $1,219 | $N/A | $N/A |
| Total Assets | $2,714 | $1,331 | $5,460 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,369 | 999 | 787 | 0 | 0 |
| Accrued Expenses | 917 | 603 | 305 | N/A | N/A |
| TOTAL | $6,486 | $2,166 | $1,173 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 11,962 | 5 | 20 | 0 | 0 |
| TOTAL | $11,962 | $5 | $20 | $N/A | $N/A |
| Total Liabilities | $18,448 | $2,170 | $1,192 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 107,958 | N/A | N/A |
| Common Shares | 116 | 109 | 108 | N/A | N/A |
| Retained earnings | -16,604 | -17,533 | -12,117 | N/A | N/A |
| TOTAL | $-15,733 | $-839 | $4,268 | $N/A | $N/A |
| Total Liabilities And Equity | $2,714 | $1,331 | $5,460 | $0 | $0 |